With 10,000 employees in 64 countries, EMD Millipore (Merck Millipore outside U.S. and Canada) had pro forma revenues of $2.9 billion for fiscal year 2009. It will be ...

With 10,000 employees in 64 countries, EMD Millipore (Merck Millipore outside U.S. and Canada) had pro forma revenues of $2.9 billion for fiscal year 2009.

Germany's Merck KGaA <MRCG.DE> on Sunday said it agreed to buy U.S. biotech tool maker Millipore Corp <MIL.N> for around $6 billion in cash, as the company looks to build its lab equipment business.

Merck is a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors. With its four divisions Merck Serono, Consumer Health, Performance ...

The deal expands Merck Millipore by multiplying its 60,000 products and solutions with the more than 230,000 chemicals, biochemicals, and other essential products Sigma-Aldrich manufactures and ...

Merck to acquire all outstanding Millipore shares for US$ 107 per share in cash, creating a world-class partner for the life science sector Agreed transaction valued at approximately € 5.3 ...

Merck to acquire Sigma-Aldrich for $140 per share in cash, valuing company at approx. $17 billion (€13.1 billion) Acquisition expands Merck Millipore’s global reach, increasing the company’s ...

The segment combines Merck’s EMD Chemicals business, located in New Jersey, and Millipore to concentrate on the life science sector, with a pro forma turnover of €2.1 billion (roughly $2.73 ...

Merck (MRK) said Sunday that it will pay $107 a share in cash for Millipore MIL, a 13% premium over Millipore's closing stock price on Feb. 26. Merck KGaA is not affiliated with U.S.-based ...

Merck KGaA’s Life Science business in the US and Canada, MilliporeSigma, has entered a definitive agreement to acquire Mirus Bio in a $600m (€500m) deal. The move aims to enhance Merck’s ...

Merck first made a play for a lead role in the market when it bought US firm Millipore for $6 billion in 2010. Merck's move for Sigma-Aldrich is the latest in a series of major merger and ...